CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

Published:2024-07 Issue: Volume:593 Page:216935
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Yao Feifan,Zhou Suiqing^ORCID,Zhang Ruizhi,Chen Yining^ORCID,Huang Wei,Yu Kai,Yang Nanmu,Qian Xiangjun,Tie Xiaofeng,Xu Jiali,Zhang Yu,Baheti Tasiken,Xu Jing,Dai Xinzheng,Hao Xiaopei,Zhang Liren,Wang Xuehao,Li Qing

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference47 articles.

1. Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca - Cancer J. Clin.,2021

2. Global epidemiology and genetics of hepatocellular carcinoma;Toh;Gastroenterology,2023

3. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors;Huang;Nat. Rev. Gastroenterol. Hepatol.,2023

4. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study;Park;Liver Int.,2015

5. [Surgical treatment of primary liver cancer:a report of 10 966 cases];Xia;Zhonghua Wai Ke Za Zhi,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment;Cell Biology and Toxicology;2024-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP